Showing results (81-90 of 372) with videos related to

Sort By:
Pageof 38
Nutrients|June 4, 2020
Omega-3 Polyunsaturated Fatty Acids Inhibit the Function of Human URAT1, a Renal Urate Re-AbsorberHiroki Saito, Yu Toyoda, Tappei Takada, et al.
Surgery Today|June 27, 2007
Salvage lymphadenectomy of the right recurrent nerve node with tracheal involvement after definitive chemoradiation therapy for esophageal squamous cell carcinoma: report of two casesYuichiro Doki, Takushi Yasuda, Hiroshi Miyata, et al.
Surgery|December 17, 2008
Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinomaTomoki Makino, Yuichiro Doki, Hiroshi Miyata, et al.
Ophthalmic Research|December 23, 2003
Variants of the myocilin gene in Japanese patients with normal-tension glaucomaKanako Izumi, Yukihiko Mashima, Minoru Obazawa, et al.
International Journal of Oncology|August 13, 2008
LC3, an autophagosome marker, is highly expressed in gastrointestinal cancersAkiko Yoshioka, Hiroshi Miyata, Yuichiro Doki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of salvage surgery for gastric wall recurrence of esophageal cancer after chemoradiotherapy]Yujiro Nakahara, Makoto Yamasaki, Hiroshi Miyata, et al.
Annals of Gastroenterological Surgery|December 3, 2019
Pathological complete response (pCR) with or without the residual intraductal carcinoma component following preoperative treatment for pancreatic cancer: Revisiting the definition of "pCR" from the prognostic standpointDaisaku Yamada, Hidenori Takahashi, Kei Asukai, et al.
Oncology Letters|January 4, 2020
Clinical features and prognostic factors in patients with esophageal cancer with bone metastasisYoshinori Imura, Sachiko Yamamoto, Toru Wakamatsu, et al.
European Radiology|August 7, 2014
Accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancerTakuro Saito, Yukinori Kurokawa, Shuji Takiguchi, et al.
Vaccine|September 15, 2014
High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccineTakuro Saito, Hisashi Wada, Makoto Yamasaki, et al.
Pageof 38